Schisandra for Cognitive Function

Research suggests that Schisandra and its bioactive compounds — including lignans, schisandrol A, schizandrin A, schisantherin A and B, and polysaccharides — may support cognitive function through multiple mechanisms, including reducing oxidative stress, suppressing neuroinflammation, protecting against amyloid-beta toxicity, modulating neurotransmitter systems, and promoting synaptic plasticity-related proteins such as BDNF. The body of evidence consists predominantly of animal model studies and cell culture experiments, with one small randomized controlled trial in humans finding improved attention and processing speed from a multi-herb adaptogen formula containing Schisandra, and several narrative reviews cataloguing its bioactive constituents and their associated effects. Studies across these models consistently point in a supportive direction, covering conditions ranging from Alzheimer's disease-like pathology to chronic stress-induced cognitive impairment, though the heavy reliance on rodent models and in vitro work means findings cannot be directly extrapolated to human outcomes. The single human trial was limited by its small sample size, single-dose design, and use of a combination product, making it difficult to attribute observed effects to Schisandra specifically, and overall the clinical evidence base remains insufficient to draw firm conclusions about efficacy in humans.